Craig Barbarosh Buys Shares of Sabra Health Care REIT

Craig Barbarosh acquired 8,310 shares of Sabra Health Care REIT, Inc. on June 17, 2026.

Written by EarningsIQ · Published Jun 19, 2026, 3:02 AM EDT · Updated Jun 20, 2026, 7:00 AM EDT

Key Points

Craig Barbarosh purchased 8,310 shares of Sabra Health Care REIT, Inc. on June 17, 2026, with no transaction value disclosed.
Sabra Health Care REIT, Inc. trades at $18.05 with a market cap of approximately $4.57 billion and a P/E ratio of 28.76.
Wells Fargo maintains a 'buy' rating on SBRA with a $23 target, while Scotiabank rates it 'hold' with a $19 target.

Craig Barbarosh, a notable insider, has bought 8,310 shares of Sabra Health Care REIT, Inc. (NasdaqGS: SBRA) as of June 17, 2026. The transaction did not disclose a specific value, and the shares were acquired at no cost. This move comes as part of a series of insider purchases on the same date.

Insider Buying and Selling at Sabra Health Care REIT, Inc.

Several insiders, including Ann Kono, Lynne Katzmann, Catherine Cusack, Michael Foster, and Jeffrey Malehorn, each acquired 8,310 shares on June 17, 2026. These purchases were not part of any pre-planned trading programs.

Other Institutional Activity in Sabra Health Care REIT

BlackRock, Inc. increased its holdings in Sabra Health Care REIT by 704,770 shares, bringing its total to 39,098,389 shares valued at about $751.86 million. Principal Financial Group Inc added 98,770 shares, ending with 25,052,121 shares worth approximately $481.75 million. State Street Corp also grew its position by 198,311 shares to a total of 12,099,951 shares, valued at $232.68 million. Meanwhile, JPMorgan Chase & Co significantly boosted its stake by 5,569,621 shares, now holding 8,201,220 shares with a value of $159.43 million.

Sabra Health Care REIT, Inc. Stock Snapshot

Shares of Sabra Health Care REIT, Inc. are trading at $18.05. The company has a market capitalization of approximately $4.57 billion and a P/E ratio of 28.76. It operates with a beta of 0.626, indicating lower volatility compared to the broader market. The stock's 52-week range is between $17.17 and $21.28, with a 50-day moving average of $19.94 and a 200-day moving average of $19.31.

Analysts Set New Price Targets

On June 18, 2026, Scotiabank maintained its 'hold' rating on Sabra Health Care REIT, setting a price target of $19. Earlier, on June 1, Wells Fargo reiterated its 'buy' rating with a $23 target. The consensus among 13 analysts is a 'buy' with an average price target of $22.77.

About Sabra Health Care REIT, Inc.

Sabra Health Care REIT, Inc. is a real estate investment trust focused on owning and investing in healthcare facilities across the United States and Canada. Based in Tustin, California, the company operates under the leadership of CEO Richard K. Matros and employs 58 people. Sabra specializes in properties that serve the healthcare industry, offering a diversified portfolio of real estate assets.

Bottom Line

Craig Barbarosh's recent purchase of Sabra Health Care REIT shares highlights ongoing insider interest in the company. Investors often watch such moves for potential insights into company prospects. However, it's important to remember that insider transactions are just one of many factors to consider in evaluating a stock's future. The stock currently trades at $18.05, and recent analyst ratings suggest a mixed outlook with a consensus 'buy' recommendation.